Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Small-Cap Snapshot: Restoration Robotics to offer a master class on robot-assisted hair restoration

Wednesday, June 13, 2018 8:01
% of readers think this story is Fact. Add your two cents.

Medical device company Restoration Robotics Inc (NASDAQ:HAIR) is offering an education master class to train physicians on how to use its hair restoration technology. Led by Dr. Robert Bernstein of the Bernstein Medical Center for Hair Restoration, the class series will feature hands-on training including a segment on hairline design. Trading under the ticker “HAIR”, the company develops the ARTAS Robotic Hair Restoration System, which uses robots to assist physicians with the procedure. Shares of the California-based company were up nearly 5% to US$3.05.

scPharamaceuticals Inc (NASDAQ:SCPH) shares sunk after the U.S. Food and Drug Administration rejected its application for its drug Furoscix. The drug is intended to treat fluid overload in heart failure patients, also known as an edema. The biopharma received a complete response letter from the FDA, asking for additional human factor studies as well as device modifications. A clinical validation study may also be necessary. Shares of the clinical-stage pharma company fell more than 20% to US$5.86.

READ: Shares of Korn/Ferry International soar after 4Q earnings beat Street on strong revenue

vTv Therapeutics Inc (NASDAQ:VTVT) released the topline results for its drug azeliragon, failing to meet the co-primary endpoints. The drug is being developed to treat patients with mild Alzheimer’s disease but has yet to show significant enough improvements versus the placebo. The company plans to meet with the FDA to discuss the next steps toward approval. Shares of the biopharma were down more than 10% to US$1.70.

Talent agency Korn/Ferry International (NYSE:KFY) shares soared after crushing Wall Street estimates and offering a positive outlook for the year ahead. The company reported fourth-quarter earnings of US$0.80 on revenue of US$488.4mln versus analysts estimates of US$0.70 EPS on revenue of US$454.4mln. For the first quarter, the company forecast earnings between US$0.67 and US$0.75 per share on revenue between US$450mln and US$470mln, once again beating consensus estimates of US$0.66 EPS on revenue of US$432.8mln. Shares of the Los Angeles-based agency jumped more than 15% to US$65.39.

The small-cap indices were in slight decline with both the Russell 2000 and the S&P 600 seeing minimal losses.

Story by ProactiveInvestors


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question Razz Sad Evil Exclaim Smile Redface Biggrin Surprised Eek Confused Cool LOL Mad Twisted Rolleyes Wink Idea Arrow Neutral Cry Mr. Green

Top Stories
Recent Stories



Top Global

Top Alternative



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.